These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6808305)

  • 1. Uptake and binding of alpha-L-iduronidase.
    Rome LH
    Methods Enzymol; 1982; 83():582-7. PubMed ID: 6808305
    [No Abstract]   [Full Text] [Related]  

  • 2. Maturation of alpha-L-iduronidase in cultured human fibroblasts.
    Myerowitz R; Neufeld EF
    J Biol Chem; 1981 Mar; 256(6):3044-8. PubMed ID: 7204389
    [No Abstract]   [Full Text] [Related]  

  • 3. A radioactive substrate and assay for alpha-L-iduronidase.
    Di Natale P; Leder IG; Neufeld EF
    Clin Chim Acta; 1977 Jun; 77(3):211-8. PubMed ID: 406106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct demonstration of binding of a lysosomal enzyme, alpha-L-iduronidase, to receptors on cultured fibroblasts.
    Rome LH; Weissmann B; Neufeld EF
    Proc Natl Acad Sci U S A; 1979 May; 76(5):2331-4. PubMed ID: 287076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alpha-L-iduronidase activity in fibroblasts of patients with Hurler syndrome].
    Stareprawo G; Grimm U; Machill G; Knapp A; Wehnert M
    Acta Biol Med Ger; 1975; 34(6):1079-82. PubMed ID: 812313
    [No Abstract]   [Full Text] [Related]  

  • 6. The relationship of alpha-L-iduronidase and Hurler corrective factor.
    Shapiro LJ; Hall CW; Leder IG; Neufeld EF
    Arch Biochem Biophys; 1976 Jan; 172(1):156-61. PubMed ID: 3136
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Chondroitinsulphaturia with alpha-L-iduronidase deficiency.
    Babarik A; Benson PF; Dean MF; Muir H
    Lancet; 1974 Aug; 2(7878):464-5. PubMed ID: 4136880
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of receptor-mediated uptake of a lysosomal enzyme into fibroblasts by chloroquine, procaine and ammonia.
    Sando GN; Titus-Dillon P; Hall CW; Neufeld EF
    Exp Cell Res; 1979 Mar; 119(2):359-64. PubMed ID: 428466
    [No Abstract]   [Full Text] [Related]  

  • 9. Recognition and receptor-mediated uptake of a lysosomal enzyme, alpha-l-iduronidase, by cultured human fibroblasts.
    Sando GN; Neufeld EF
    Cell; 1977 Nov; 12(3):619-27. PubMed ID: 922886
    [No Abstract]   [Full Text] [Related]  

  • 10. Substrates for the assay of alpha-L-iduronidase.
    Thompson JN
    Clin Chim Acta; 1978 Nov; 89(3):435-46. PubMed ID: 709885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic substrates for alpha-L-iduronidase.
    Weissmann B
    Methods Enzymol; 1978; 50():141-50. PubMed ID: 661571
    [No Abstract]   [Full Text] [Related]  

  • 12. Human kidney alpha-L-iduronidase: purification and characterization.
    Rome LH; Garvin AJ; Neufeld EF
    Arch Biochem Biophys; 1978 Aug; 189(2):344-53. PubMed ID: 30407
    [No Abstract]   [Full Text] [Related]  

  • 13. Butanedione treatment reduces receptor binding of a lysosomal enzyme to cells and membranes.
    Rome LH; Miller J
    Biochem Biophys Res Commun; 1980 Feb; 92(3):986-93. PubMed ID: 7362619
    [No Abstract]   [Full Text] [Related]  

  • 14. A nonpathologic allele (IW) for low alpha-L-iduronidase enzyme activity vis-a-vis prenatal diagnosis of Hurler syndrome.
    Whitley CB; Gorlin RJ; Krivit W
    Am J Med Genet; 1987 Sep; 28(1):233-43. PubMed ID: 3118714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparan sulfate and dermatan sulfate from the liver of a patient with Hurler syndrome: high performance liquid chromatography of their degradation products after incubation with alpha-L-iduronidase-deficient fibroblasts.
    Minami R; Fujibayashi S; Igarashi C; Ishikawa Y; Wagatsuma K; Nakao T; Tsugawa S
    Clin Chim Acta; 1984 Feb; 137(2):179-87. PubMed ID: 6231139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha-L-iduronidase from human kidney.
    Rome LH
    Methods Enzymol; 1982; 83():578-82. PubMed ID: 7098949
    [No Abstract]   [Full Text] [Related]  

  • 17. Assay and purification of a solubilized membrane receptor that binds the lysosomal enzyme alpha-L-iduronidase.
    Steiner AW; Rome LH
    Arch Biochem Biophys; 1982 Apr; 214(2):681-7. PubMed ID: 7092215
    [No Abstract]   [Full Text] [Related]  

  • 18. Glycosidase active site mutations in human alpha-L-iduronidase.
    Brooks DA; Fabrega S; Hein LK; Parkinson EJ; Durand P; Yogalingam G; Matte U; Giugliani R; Dasvarma A; Eslahpazire J; Henrissat B; Mornon JP; Hopwood JJ; Lehn P
    Glycobiology; 2001 Sep; 11(9):741-50. PubMed ID: 11555618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of alpha-L-iduronidase activity in various tissues from two sibs affected with presumably the Hurler-Scheie compound syndrome.
    Thompson JN; Finley SC; Lorincz AE; Finley WH
    Birth Defects Orig Artic Ser; 1975; 11(6):341-6. PubMed ID: 811284
    [No Abstract]   [Full Text] [Related]  

  • 20. Human alpha-L-iduronidase. II. Comparative biochemical and immunologic properties of the purified low and high uptake forms.
    Schuchman EH; Guzman NA; Takada G; Desnick RJ
    Enzyme; 1984; 31(3):166-75. PubMed ID: 6734578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.